再鼎医药股价上涨,业绩与管线双驱动获机构看好

财中社
06 Mar

3月6日,再鼎医药(09688)开盘价28港元,收盘价28.25港元;近五日涨跌幅-1.91%。虽然近五日涨幅趋弱,但实际上,再鼎医药近一月涨幅38.48%,近三月涨幅29%,近六月涨幅80.17%,近一年涨幅86.59%。根据2024年财报,再鼎医药全年总收入3.99亿美元,同比增长50%;第四季度收入1.09亿美元,同比增66%。核心产品艾加莫德(卫伟迦)全年销售额达9360万美元(因2023...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10